New vaccine aims to tame hepatitis b without lifelong drugs
Disease control
Terminated
This study tested a vaccine called HepTcell in 87 adults with inactive chronic hepatitis B who had low levels of the virus. The goal was to see if the vaccine could lower hepatitis B surface antigen (HBsAg) or clear it from the blood. The study was stopped early, so results are l…
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC